Hannah Joseph Hospital IPO
UpcomingAlready have an account? Apply now
Hannah Joseph Hospital IPO details
Schedule of Hannah Joseph Hospital
| Issue open date | 22 Jan 2026 |
| Issue close date | 27 Jan 2026 |
| UPI mandate deadline | 27 Jan 2026 (5 PM) |
| Allotment finalization | 28 Jan 2026 |
| Refund initiation | 29 Jan 2026 |
| Share credit | 29 Jan 2026 |
| Listing date | 30 Jan 2026 |
| Mandate end date | 11 Feb 2026 |
| Lock-in end date for anchor investors (50%) | 27 Feb 2026 |
| Lock-in end date for anchor investors (remaining) | 28 Apr 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Hannah Joseph Hospital
Hannah Joseph Hospital Limited is a multi-specialty healthcare provider based in Madurai, Tamil Nadu. Founded in 2008 by Dr. Mosesjoseph Arunkumar as a neurology-focused hospital, it was incorporated in 2011 and converted into a public limited company in 2022. The hospital operates on a two-acre campus with 150 beds. It offers advanced medical and surgical care across neurology, cardiology, psychiatry, and trauma, supported by modern infrastructure, including a cath lab, cardiac operating theatres, and comprehensive neuroradiology facilities.
The hospital has built a strong reputation for complex neurosurgical and cardiac procedures and is accredited by NABH and NABL, reflecting its focus on quality and patient safety. It follows an integrated care model backed by experienced clinicians and emergency-ready teams. Hannah Joseph Hospital is empanelled under government health insurance schemes such as TNNHIS and CMCHIS, enabling cashless treatment for a wide section of the population.
Financials of Hannah Joseph Hospital
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 42 |
| Fresh Issue – Proceeds go to the company | 42 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Funding of capital expenditure | 34.98 (83.29%) |
| General corporate purposes | 7.02 (16.71%) |
Strengths
- Strong leadership with over 20 years of medical experience by the promoter-doctors.
- Leading neurology and neurosurgery centre in Madurai and South Tamil Nadu.
- NABH and NABL accredited hospital with advanced medical infrastructure.
- 150-bed multi-specialty hospital offering complex neuro and cardiac procedures.
- Recognised nationally with multiple awards for neuroscience and trauma care.
Risks
- High dependence on in-patient revenue, contributing over 65% of total income.
- Operations concentrated in a single geographic location in Madurai.
- Key facilities operate on leased properties owned by promoters.
- Healthcare business is subject to strict regulatory and compliance requirements.
- Intense competition from larger hospital chains and regional players.